CVS Health Stock Pops

CVS Health Stock Pops as Q4 Sales, Earnings Top Estimates
Shares of CVS Health (CVS) surged Wednesday morning after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results. CVS reported adjusted earnings per share (EPS) of $1.
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance set at $5.75-$6.00.
CVS Health Stock Is Relatively Cheap, Analyst Highlights Cost Trend Pressure Ahead Of Q4 Earnings
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall Street estimates fourth-quarter adjusted EPS of $0.94 and sales of $97.20 billion,
CVS Health reports hike in Q4, full year revenue
CVS Health’s revenues increased 4.2% in both the quarter and year, compared to the prior year driven by growth in the health care benefits and pharmacy and consumer wellness segments.
CVS Health: Q4 Earnings Snapshot
The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 89 cents per share. The drugstore chain and pharmacy benefits manager posted revenue of $97.71 billion in the period,
CVS Health Stock Up on Q4 Earnings & Revenue Beat, Margins Rise
CVS Health Corporation CVS posted adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, down 43.9% year over year. However, the metric topped the Zacks Consensus Estimate by 33.7%.
CVS Beats EPS Estimates, Losses Loom
CVS Health (NYSE:CVS), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 ...
CVS Health Forecasts 10% Earnings Growth For 2025, Citing Aetna's 'Meaningful Recovery'
CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...
CVS Health sees FY25 adjusted EPS $5.75-$6.00, consensus $5.97
Sees FY25 free cash flow $6.5B. The company said, “The Company issued its full-year 2025 GAAP diluted EPS guidance range of $4.58 to $4.83 and ...
5 Things to Know Before the Stock Market Opens
U.S. stock futures are little changed as investors watch for January inflation data, and Fed Chair Jerome Powell is set to ...
FY2024 EPS Estimates for CVS Health Lowered by Analyst
Leerink Partnrs dropped their FY2024 EPS estimates for CVS Health in a report released on Monday, January 27th. Leerink Partnrs analyst M. Cherny now forecasts that the pharmacy operator will earn $5.
CVS Health reports Q4 adjusted EPS $1.19, consensus 92c
Reports Q4 revenue $97.7B, consensus $96.88B. The company said, “Our integrated model allows us to uniquely deliver a simpler, connected ...
CVS Group (LON:CVSG) shareholders have endured a 44% loss from investing in the stock three years ago
CVS Group plc (LON:CVSG) shareholders should be happy to see the share price up 20% in the last month. But that doesn't change the fact that the returns over the last three years have been less than ...
CVS Health beats quarterly profit estimates on lower medical costs
CVS Health reported a smaller-than-expected drop in fourth-quarter profit on Wednesday as its pace of medical cost increases ...